Last Close
Apr 02  •  04:00PM ET
33.43
Dollar change
+0.08
Percentage change
0.25
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y26.62% Total Holdings63 Perf Week3.49%
SponsorFranklin Templeton ETF Type Tagsequity Return% 3Y4.20% AUM21.72M Perf Month-1.34%
Fund Family Bond Type Tagshealthcare Return% 5Y-3.99% NAV/sh Perf Quarter-7.92%
Index- Average Maturity Tagsgenomics Return% 10Y 52W High38.17 -12.41% Perf Half Y5.06%
Index Weighting Commodity Type Tags- Return% SI 52W Low23.74 40.83% Perf YTD-7.92%
Active/Passive Quant Type Tags- Flows% 1M0.00% Volatility0.25% 0.50% Perf Year23.67%
Dividend TTM0.14 (0.43%) ESG Type Tags- Flows% 3M9.41% ATR (14)0.52 Perf 3Y10.04%
Dividend Ex-DateDec 30, 2025 Dividend Type Sector/Theme Flows% YTD9.41% RSI (14)53.34 Perf 5Y-23.78%
Dividend Gr. 3/5Y- 95.56% Structure Type Region Flows% 1Y Beta1.08 Perf 10Y-
Expense0.50% Growth/Value SMA202.92% Flows% 3Y Rel Volume4.16 Prev Close33.35
Inverse/Leveraged Market Cap SMA50-2.27% Flows% 5Y Avg Volume1.32K Price33.43
IPOFeb 27, 2020 Option/ShortYes / No SMA2001.91% Trades Volume5,478 Change0.25%
Franklin Genomic Advancements ETF seeks capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.